Maiken Thyregod Joergensen
Overview
Explore the profile of Maiken Thyregod Joergensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andersen V, Pingel J, Sofelt H, Hikmat Z, Johansson M, Pedersen V, et al.
Lancet Gastroenterol Hepatol
. 2024 Oct;
9(11):1041-1051.
PMID: 39395438
Extensive patient heterogeneity is a challenge in the management of inflammatory bowel disease (IBD). Sex and gender, as well as the interaction of sex and gender with other social identities,...
2.
Tan M, Brusgaard K, Gerdes A, Larsen M, Mortensen M, Detlefsen S, et al.
Ann Hum Genet
. 2022 Mar;
86(4):195-206.
PMID: 35312039
No abstract available.
3.
Tan M, Brusgaard K, Gerdes A, Mortensen M, Detlefsen S, de Muckadell O, et al.
Clin Genet
. 2021 Jul;
100(5):551-562.
PMID: 34313325
First-degree relatives (FDRs) of familial pancreatic cancer (FPC) patients have increased risk of developing pancreatic ductal adenocarcinoma (PDAC). Investigating and understanding the genetic basis for PDAC susceptibility in FPC predisposed...
4.
Tan M, Brusgaard K, Gerdes A, Mortensen M, Detlefsen S, de Muckadell O, et al.
Scand J Gastroenterol
. 2021 Jun;
56(8):965-971.
PMID: 34165379
Background: Familial Pancreatic Cancer (FPC) is responsible for up to 10% of all cases of pancreatic ductal adenocarcinoma (PDAC). Individuals predisposed for FPC have an estimated lifetime risk of 16-39%...
5.
Tan M, de Muckadell O, Joergensen M
J Pancreat Cancer
. 2020 Aug;
6(1):73-84.
PMID: 32783019
High-grade pancreatic intraepithelial neoplasia (PanIN) are aggressive premalignant lesions, associated with risk of progression to pancreatic ductal adenocarcinoma (PDAC). A depiction of co-dysregulated gene activity in high-grade familial pancreatic cancer...
6.
Kjellman M, Knigge U, Welin S, Thiis-Evensen E, Gronbaek H, Schalin-Jantti C, et al.
Neuroendocrinology
. 2020 Jul;
111(9):840-849.
PMID: 32721955
Background: Small intestinal neuroendocrine tumors (SI-NETs) are difficult to diagnose in the early stage of disease. Current blood biomarkers such as chromogranin A (CgA) and 5-hydroxyindolacetic acid have low sensitivity...
7.
Detlefsen S, Joergensen M, Mortensen M
Pathol Int
. 2017 Sep;
67(10):514-520.
PMID: 28868649
The International Consensus Diagnostic Criteria (ICDC) for the diagnosis of autoimmune pancreatitis (AIP) include the histological criterion that is based on either pancreatic core needle biopsies (CNBs) or surgical specimens....
8.
Joergensen M, Gerdes A, Sorensen J, Schaffalitzky de Muckadell O, Mortensen M
Pancreatology
. 2016 Apr;
16(4):584-92.
PMID: 27090585
Objective: Pancreatic cancer (PC) is the fourth leading cause of cancer death worldwide, symptoms are few and diffuse, and when the diagnosis has been made only 10-15% would benefit from...
9.
Carlsen A, Joergensen M, Knudsen S, de Muckadell O, Heegaard N
Pancreas
. 2013 Sep;
42(7):1107-13.
PMID: 24048453
Objectives: There are no tumor-specific biochemical markers for pancreatic ductal adenocarcinoma (PDAC). Tissue-specific gene expression including microRNA (miRNA) profiling, however, identifies specific PDAC signatures. This study evaluates associations between circulating,...
10.
Joergensen M, Brusgaard K, Novovic S, Moller Andersen A, Hansen M, Gerdes A, et al.
Eur J Gastroenterol Hepatol
. 2012 Jan;
24(3):309-15.
PMID: 22228370
Objectives: Serine Protease Inhibitor Kazal type 1 (SPINK1) protects against premature intracellular activation of trypsinogen and development of acute pancreatitis. Our aim was to determine the prevalence of SPINK1 mutations...